RESEARCH-USE BIOSIMILAR ANTIBODY
Tadocizumab
Antibody fragment · IgG1
Tadocizumab (C4G1; YM-337) is a humanized monoclonal antibody tageting integrin αIIbβ3. Tadocizumab has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research.
TARGETITGA2B_ITGB3
YAntibody fragment
CATALOGSC-BS-144
CATALOG NUMBERSC-BS-144
MOLECULAR WEIGHTApprox. 47.619 kDa
PRODUCT FORMATAntibody fragment
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Tadocizumab (C4G1; YM-337) is a humanized monoclonal antibody tageting integrin αIIbβ3. Tadocizumab has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research.
Tadocizumab is a recombinant research-use antibody directed against ITGA2B_ITGB3.